Literature DB >> 32005602

QuantiFERON-CMV guided virostatic prophylaxis after heart transplantation.

Gregor Poglajen1, Gregor Zemljič2, Sabina Frljak2, Andraž Cerar2, Vesna Andročec2, Tamara Božič3, Mojca Bitenc3, Renata Okrajšek2, Miran Šebeštjen2, Bojan Vrtovec1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32005602     DOI： 10.1016/j.healun.2020.01.001

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  3 in total

Review 1.  Utility of Cytomegalovirus Cell-Mediated Immunity Assays in Solid Organ Transplantation.

Authors:  Victoria G Hall; Atul Humar; Deepali Kumar
Journal:  J Clin Microbiol       Date:  2022-05-11       Impact factor: 11.677

Review 2.  Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update.

Authors:  Katya Prakash; Aditya Chandorkar; Kapil K Saharia
Journal:  Diagnostics (Basel)       Date:  2021-05-13

3.  Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review.

Authors:  Omid Rezahosseini; Dina Leth Møller; Andreas Dehlbæk Knudsen; Søren Schwartz Sørensen; Michael Perch; Finn Gustafsson; Allan Rasmussen; Sisse Rye Ostrowski; Susanne Dam Nielsen
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.